Recombinant human keratinocyte growth factor-2 - Anhui Anke BiotechnologyAlternative Names: FGF-10 - Anhui Anke Biotechnology; rhKGF-2 - Anhui Anke Biotechnology
Latest Information Update: 25 Nov 2015
At a glance
- Originator Newsummit Biopharma
- Developer Anhui Anke Biotechnology
- Class Fibroblast growth factors
- Mechanism of Action Fibroblast growth factor stimulants; Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Wounds
Most Recent Events
- 25 Nov 2015 Clinical trials in Wounds in China (Topical)